Mol Cell Biol. 1994 February; 14(2): 1220-1229
Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice.
K J Lee,
R Hickey,
H Zhu and
K R Chien
Department of Medicine, University of California, San Diego School of Medicine, La Jolla 92093.
ABSTRACT
The cardiac myosin light-chain 2v (MLC-2v) gene has served as a model system to identify the pathways which restrict the expression of cardiac muscle genes to particular chambers of the heart during cardiogenesis. To identify the critical cis regulatory elements which mediate ventricular chamber-specific expression of the MLC-2v gene in the in vivo context, a series of transgenic mice which harbor mutations in putative MLC-2 cis regulatory elements in a 250-bp MLC-2-luciferase fusion gene which is expressed in a ventricular chamber-specific fashion in transgenic mice were generated. These studies demonstrate that both components of HF-1 (HF-1a and HF-1b/MEF-2) are required to maintain ventricular chamber-specific expression and function as positive regulatory elements. Mutations in another conserved element (HF-2) are without statistically significant effect on ventricular chamber expression. Transgenics harboring mutations in the E-box site also displayed significant upregulation of reporter activity in the soleus, gastrocnemius, and uterus, with a borderline effect on expression in liver. Mutations in another conserved element (HF-3) result in a marked (> 75-fold) upregulation of the luciferase reporter activity in the soleus muscle of multiple independent or transgenic founders. Since the HF-3 mutations appeared to have only a marginal effect on luciferase reporter activity in liver tissue, HF-3 appears to function as a novel negative regulatory element to primarily suppress expression in muscle tissues. Thus, a combination of positive (HF-1a/HF-1b) and negative (E-box and HF-3) regulatory elements appear to be required to maintain ventricular chamber-specific expression in the in vivo context.
Mol Cell Biol. 1994 February; 14(2): 1220-1229
This article has been cited by other articles:
-
Su, H., Joho, S., Huang, Y., Barcena, A., Arakawa-Hoyt, J., Grossman, W., Kan, Y. W.
(2004). Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc. Natl. Acad. Sci. USA
101: 16280-16285
[Abstract]
[Full Text]
-
Mathew, S., Mascareno, E., Siddiqui, M. A. Q.
(2004). A Ternary Complex of Transcription Factors, Nished and NFATc4, and Co-activator p300 Bound to an Intronic Sequence, Intronic Regulatory Element, Is Pivotal for the Up-regulation of Myosin Light Chain-2v Gene in Cardiac Hypertrophy. J. Biol. Chem.
279: 41018-41027
[Abstract]
[Full Text]
-
Phillips, M. I., Tang, Y., Schmidt-Ott, K., Qian, K., Kagiyama, S.
(2002). Vigilant Vector: Heart-Specific Promoter in an Adeno-Associated Virus Vector for Cardioprotection. Hypertension
39: 651-655
[Abstract]
[Full Text]
-
Lewis, A. L., Xia, Y., Datta, S. K., McMillin, J., Kellems, R. E.
(1999). Combinatorial Interactions Regulate Cardiac Expression of the Murine Adenylosuccinate Synthetase 1 Gene. J. Biol. Chem.
274: 14188-14197
[Abstract]
[Full Text]
-
Esser, K., Nelson, T., Lupa-Kimball, V., Blough, E.
(1999). The CACC Box and Myocyte Enhancer Factor-2 Sites within the Myosin Light Chain 2 Slow Promoter Cooperate in Regulating Nerve-specific Transcription in Skeletal Muscle. J. Biol. Chem.
274: 12095-12102
[Abstract]
[Full Text]
-
Naya, F., Wu, C, Richardson, J., Overbeek, P, Olson, E.
(1999). Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development
126: 2045-2052
[Abstract]
-
Doevendans, P. A., Ruiz-Lozano, P., van Bilsen, M.
(1998). Hunting down nucleic acid binding factors in the cardiovascular system. Cardiovasc Res
38: 301-315
[Abstract]
[Full Text]
-
Franco, D., Lamers, W. H, Moorman, A. F.M
(1998). Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res
38: 25-53
[Full Text]
-
Gruber, P., Kubalak, S., Chien, K.
(1998). Downregulation of atrial markers during cardiac chamber morphogenesis is irreversible in murine embryos. Development
125: 4427-4438
[Abstract]
-
Lupa-Kimball, V. A., Esser, K. A.
(1998). Use of DNA injection for identification of slow nerve-dependent regions of the MLC2s gene. Am. J. Physiol. Cell Physiol.
274: C229-C235
[Abstract]
[Full Text]
-
Qin, W., Khuchua, Z., Klein, S. C., Strauss, A. W.
(1997). Elements Regulating Cardiomyocyte Expression of the Human Sarcomeric Mitochondrial Creatine Kinase Gene in Transgenic Mice. J. Biol. Chem.
272: 25210-25216
[Abstract]
[Full Text]
-
Dhar, M., Mascareno, E. M., Siddiqui, M. A. Q.
(1997). Two Distinct Factor-binding DNA Elements in Cardiac Myosin Light Chain 2 Gene Are Essential for Repression of Its Expression in Skeletal Muscle. ISOLATION OF A cDNA CLONE FOR REPRESSOR PROTEIN NISHED. J. Biol. Chem.
272: 18490-18497
[Abstract]
[Full Text]
-
Zou, Y, Evans, S, Chen, J, Kuo, H., Harvey, R., Chien, K.
(1997). CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development
124: 793-804
[Abstract]
-
Moriscot, A. S., Sayen, M. R., Hartong, R., Wu, P., Dillmann, W. H.
(1997). Transcription of the Rat Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatase Gene Is Increased by 3,5,3'-Triiodothyronine Receptor Isoform-Specific Interactions with the Myocyte-Specific Enhancer Factor-2a. Endocrinology
138: 26-32
[Abstract]
[Full Text]
-
Ritchie, M. E., Ritchie, M. E.
(1996). Characterization of Human B Creatine Kinase Gene Regulation in the Heart in Vitro and in Vivo. J. Biol. Chem.
271: 25485-25491
[Abstract]
[Full Text]
-
Wang, G. F., Nikovits, W. Jr., Schleinitz, M., Stockdale, F. E.
(1996). Atrial Chamber-specific Expression of the Slow Myosin Heavy Chain 3Gene in the Embryonic Heart. J. Biol. Chem.
271: 19836-19845
[Abstract]
[Full Text]
-
Mably, J. D., Liew, C.-C.
(1996). Factors Involved in Cardiogenesis and the Regulation of Cardiac-Specific Gene Expression. Circ. Res.
79: 4-13
[Abstract]
[Full Text]
-
Farrance, I. K. G., Ordahl, C. P.
(1996). The Role of Transcription Enhancer Factor-1 (TEF-1) Related Proteins in the Formation of M-CAT Binding Complexes in Muscle and Non-muscle Tissues. J. Biol. Chem.
271: 8266-8274
[Abstract]
[Full Text]
-
Schmoelzl, S., Leeb, T., Brinkmeier, H., Brem, G., Brenig, B.
(1996). Regulation of Tissue-specific Expression of the Skeletal Muscle Ryanodine Receptor Gene. J. Biol. Chem.
271: 4763-4769
[Abstract]
[Full Text]
-
Becker, K. D., Gottshall, K. R., Chien, K. R.
(1996). Strategies for Studying Cardiovascular Phenotypes in Genetically Manipulated Mice. Hypertension
27: 495-501
[Abstract]
[Full Text]
-
Ross, R., Navankasattusas, S, Harvey, R., Chien, K.
(1996). An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and established an anterior-posterior gradient of expression. Development
122: 1799-1809
[Abstract]
-
Hunter, J. J., Tanaka, N., Rockman, H. A., Ross, J. Jr., Chien, K. R.
(1995). Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice. J. Biol. Chem.
270: 23173-23178
[Abstract]
[Full Text]
-
Wang, G. F., Nikovits, W. Jr., Bao, Z.-Z., Stockdale, F. E.
(2001). Irx4 Forms an Inhibitory Complex with the Vitamin D and Retinoic X Receptors to Regulate Cardiac Chamber-specific slow MyHC3 Expression. J. Biol. Chem.
276: 28835-28841
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.